Cargando…

More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients

BACKGROUND: Immunocompromised adults are more vulnerable to a complicated course of viral respiratory tract infections (RTI). OBJECTIVES: Provide evidence on the effect of implementation of rapid molecular diagnostics for viruses on use of in-hospital isolation facilities, oseltamivir and antibiotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Vos, Laura M., Weehuizen, Jesper M., Hoepelman, Andy I.M., Kaasjager, Karin H.A.H., Riezebos-Brilman, Annelies, Oosterheert, Jan Jelrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185605/
https://www.ncbi.nlm.nih.gov/pubmed/30999234
http://dx.doi.org/10.1016/j.jcv.2019.04.003
_version_ 1783526791617445888
author Vos, Laura M.
Weehuizen, Jesper M.
Hoepelman, Andy I.M.
Kaasjager, Karin H.A.H.
Riezebos-Brilman, Annelies
Oosterheert, Jan Jelrik
author_facet Vos, Laura M.
Weehuizen, Jesper M.
Hoepelman, Andy I.M.
Kaasjager, Karin H.A.H.
Riezebos-Brilman, Annelies
Oosterheert, Jan Jelrik
author_sort Vos, Laura M.
collection PubMed
description BACKGROUND: Immunocompromised adults are more vulnerable to a complicated course of viral respiratory tract infections (RTI). OBJECTIVES: Provide evidence on the effect of implementation of rapid molecular diagnostics for viruses on use of in-hospital isolation facilities, oseltamivir and antibiotic usage, and other clinical outcomes in immunocompromised patients. STUDY DESIGN: A before-after study during two consecutive respiratory viral seasons, including immunocompromised adult patients presenting at a tertiary care emergency department with clinical suspicion of RTI. During the first season (2016/2017), respiratory viruses were detected using inhouse real-time PCR. The second season (2017/2018), we implemented a diagnostic flowchart including a rapid molecular test for 15 respiratory viruses (FilmArray®). We assessed the effect of this implementation on need for isolation, antivirals and empirical antibiotics. RESULTS: We included 192 immunocompromised adult patients during the first and 378 during the second season. Respiratory viral testing was performed in 135 patients (70%) during the first and 284 (75%) during the second season (p = 0.218) of which 213 (75%) using the rapid test. After implementation, use of in-hospital isolation facilities was reduced (adjusted odds ratio 0.35, 95%CI 0.19-0.64). Furthermore, adequate use of oseltamivir improved, with fewer prescriptions in influenza negative patients (0.15, 95%CI 0.08-0.28) and more in influenza positive patients (11.13, 95%CI 1.75–70.86). No effect was observed on empirical antibiotic use, hospital admissions, length of hospital stay or safety outcomes. CONCLUSIONS: Implementation of rapid molecular testing for respiratory viruses in adult immunocompromised patients results in more adequate use of oseltamivir and in-hospital isolation facilities without compromising safety.
format Online
Article
Text
id pubmed-7185605
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71856052020-04-28 More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients Vos, Laura M. Weehuizen, Jesper M. Hoepelman, Andy I.M. Kaasjager, Karin H.A.H. Riezebos-Brilman, Annelies Oosterheert, Jan Jelrik J Clin Virol Article BACKGROUND: Immunocompromised adults are more vulnerable to a complicated course of viral respiratory tract infections (RTI). OBJECTIVES: Provide evidence on the effect of implementation of rapid molecular diagnostics for viruses on use of in-hospital isolation facilities, oseltamivir and antibiotic usage, and other clinical outcomes in immunocompromised patients. STUDY DESIGN: A before-after study during two consecutive respiratory viral seasons, including immunocompromised adult patients presenting at a tertiary care emergency department with clinical suspicion of RTI. During the first season (2016/2017), respiratory viruses were detected using inhouse real-time PCR. The second season (2017/2018), we implemented a diagnostic flowchart including a rapid molecular test for 15 respiratory viruses (FilmArray®). We assessed the effect of this implementation on need for isolation, antivirals and empirical antibiotics. RESULTS: We included 192 immunocompromised adult patients during the first and 378 during the second season. Respiratory viral testing was performed in 135 patients (70%) during the first and 284 (75%) during the second season (p = 0.218) of which 213 (75%) using the rapid test. After implementation, use of in-hospital isolation facilities was reduced (adjusted odds ratio 0.35, 95%CI 0.19-0.64). Furthermore, adequate use of oseltamivir improved, with fewer prescriptions in influenza negative patients (0.15, 95%CI 0.08-0.28) and more in influenza positive patients (11.13, 95%CI 1.75–70.86). No effect was observed on empirical antibiotic use, hospital admissions, length of hospital stay or safety outcomes. CONCLUSIONS: Implementation of rapid molecular testing for respiratory viruses in adult immunocompromised patients results in more adequate use of oseltamivir and in-hospital isolation facilities without compromising safety. Elsevier B.V. 2019-07 2019-04-07 /pmc/articles/PMC7185605/ /pubmed/30999234 http://dx.doi.org/10.1016/j.jcv.2019.04.003 Text en © 2019 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Vos, Laura M.
Weehuizen, Jesper M.
Hoepelman, Andy I.M.
Kaasjager, Karin H.A.H.
Riezebos-Brilman, Annelies
Oosterheert, Jan Jelrik
More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients
title More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients
title_full More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients
title_fullStr More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients
title_full_unstemmed More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients
title_short More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients
title_sort more targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185605/
https://www.ncbi.nlm.nih.gov/pubmed/30999234
http://dx.doi.org/10.1016/j.jcv.2019.04.003
work_keys_str_mv AT voslauram moretargeteduseofoseltamivirandinhospitalisolationfacilitiesafterimplementationofamultifacetedstrategyincludingarapidmoleculardiagnosticpanelforrespiratoryvirusesinimmunocompromisedadultpatients
AT weehuizenjesperm moretargeteduseofoseltamivirandinhospitalisolationfacilitiesafterimplementationofamultifacetedstrategyincludingarapidmoleculardiagnosticpanelforrespiratoryvirusesinimmunocompromisedadultpatients
AT hoepelmanandyim moretargeteduseofoseltamivirandinhospitalisolationfacilitiesafterimplementationofamultifacetedstrategyincludingarapidmoleculardiagnosticpanelforrespiratoryvirusesinimmunocompromisedadultpatients
AT kaasjagerkarinhah moretargeteduseofoseltamivirandinhospitalisolationfacilitiesafterimplementationofamultifacetedstrategyincludingarapidmoleculardiagnosticpanelforrespiratoryvirusesinimmunocompromisedadultpatients
AT riezebosbrilmanannelies moretargeteduseofoseltamivirandinhospitalisolationfacilitiesafterimplementationofamultifacetedstrategyincludingarapidmoleculardiagnosticpanelforrespiratoryvirusesinimmunocompromisedadultpatients
AT oosterheertjanjelrik moretargeteduseofoseltamivirandinhospitalisolationfacilitiesafterimplementationofamultifacetedstrategyincludingarapidmoleculardiagnosticpanelforrespiratoryvirusesinimmunocompromisedadultpatients